Stay updated on Intranasal Vasopressin in Autism Children Clinical Trial
Sign up to get notified when there's something new on the Intranasal Vasopressin in Autism Children Clinical Trial page.

Latest updates to the Intranasal Vasopressin in Autism Children Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2; no user-facing content or study details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision: v3.4.1 has been added, replacing v3.4.0. There are no visible changes to the study design, endpoints, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedA glossary is now shown to help users interpret terms used in the study details page. Minor text and labeling updates (including version reference) were also applied.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 removed; this appears to be a site version update that does not change the study details or user-facing functionality.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded a Locations section with California listed as a location. Removed the California Locations item and the HHS Vulnerability Disclosure from the footer; revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Intranasal Vasopressin in Autism Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intranasal Vasopressin in Autism Children Clinical Trial page.